News of Pharmaceuticals | Healthcare | Wellness in Gujarat

US FDA issues form 483 to Alembic Pharma’s Panelav facility for oral solids

VADODARA (BARODA) | MUMBAI | RAJKOT – In a regulatory update filed to the Indian Bourses on Friday, Alembic Pharmaceuticals Ltd said of having got their Panelav facility manufacturing general oral solids inspected by US FDA (Food & Drugs Administration) and the regulator having slammed Form 483 to the facility, after inspection. The United States

Zydus Cadila gets US FDA nod to market drug for treatment of epilepsy

AHMEDABAD | MUMBAI | RAJKOT – In a press release submitted to the Indian Bourses on Tuesday, Cadila Healthcare Ltd (Dr Pankaj Patel owned Zydus Cadila group) said of having availed regulatory approval from US Food and Drugs Administration (USFDA) to market drug to treat epilepsy. Zydus Cadila has received the final approval from the

USFDA successfully inspects Alembic’s JV facility Aleor Derma

VADODARA (BARODA) | MUMBAI | RAJKOT – In a press release submitted to the Exchanges in India on Monday, in wee hours before the trading session kicked-off on the Indian Bourses, Alembic Pharmaceuticals Ltd said of Aleor Dermaceuticals Ltd’s facility, getting successfully inspected by USFDA. Aleor Dermaceuticals Ltd. (Aleor), a 60:40 Joint Venture between Alembic

Zydus Cadila gets US FDA nod to market anti-arthritis drug

AHMEDABAD | MUMBAI | RAJKOT – In a regulatory filing submitted to the Indian Bourses on Thursday, Ahmedabad headquartered and Dr Pankaj Patel led Cadila Healthcare Ltd (Zydus Cadila Group) said of having received regulatory approvals from US FDA (Food & Drugs Department) to market anti-arthritis drug. Zydus Cadila has received the tentative approval from

Zydus Cadila gets US FDA nod to market skin-care ointment

AHMEDABAD | MUMBAI | RAJKOT – In a press release submitted to the exchanges in India on Wednesday, Cadila Healthcare Ltd (Dr Pankaj Patel led Zydus Cadila Group) said of having got approval from US FDA (Food & Drugs Administration) to market skin-care ointment. Zydus Cadila has received the final approval from the USFDA to

Alembic gets US FDA nod to market diet-exercise equivalent pill, for diabetics

VADODARA (BARODA) | MUMBAI | RAJKOT – In a regulatory filing submitted on Tuesday, Vadodara headquartered and Amin family owned Alembic Pharma said of having got approval from US FDA (Food & Drugs Administration) to market diet and exercise equivalent pill for diabetic patients. Alembic Pharmaceuticals Limited today announced that the company has received tentative

Lincoln Pharma invests in renewable energy assets to save on energy cost

AHMEDABAD | MUMBAI | RAJKOT – In a regulatory update submitted to the Indian Bourses on Monday, Ahmedabad headquartered Lincoln Pharmaceuticals Ltd said of having invested in renewable energy assets to save on energy cost and improve financials, as well having applied for permission to set-up Active Pharmaceuticals Ingredients (API) manufacturing unit. The Company has

Zydus Biologics (of Zydus Cadila Group) inspected successfully by US FDA

AHMEDABAD | MUMBAI | RAJKOT – In a press-release submitted to the Indian Bourses, Cadila Healthcare Ltd (Dr Pankaj Patel led Zydus Cadila Group) said of one of the company’s subsidiary facilities being inspected successfully by US Food & Drug Administration. The Company’s Biologics manufacturing facility (Zydus Biologics) located at the Zydus Biotech Park in

Maruti Suzuki partners with Zydus Hospitals, sets up modern polyclinic

BECHARAJI (HANSALPUR) | MEHSANA | AHMEDABAD | NEW DELHI | MUMBAI | RAJKOT – In a press-release submitted to the exchanges in India on Wednesday, Maruti Suzuki India Ltd said of having partnered with Zydus Hospitals to set-up a modern polyclinic (health centre) facility at Becharaji, vide corporate social responsibility initiative. Access to quality and

Zydus Cadila gets US FDA nod to market osteoporosis, ortho treatment drug

MUMBAI | AHMEDABAD | RAJKOT – Dr Pankaj Patel led and Ahmedabad headquartered Zydus Cadila Group (Cadila Healthcare Ltd) has received final approval from the US regulators to market ortho treatment medicine, the company said in a press release submitted to the Indian Bourses, today. Zydus Cadila has received the final approval from the USFDA

Zydus Cadila keen to set-up mfg facility at Hyderabad, reports Telangana Today

HYDERABAD | AHMEDABAD | RAJKOT – Ahmedabad headquartered and Dr Pankaj Patel led Zydus Cadila Group (Cadila Healthcare Ltd) is keen to establish setting-up a facility in the upcoming Hyderabad Pharma City, Telengana Today reports Quoting Dr Pankaj Patel as told to Telengana Today, the report said of Cadila Healthcare in future to surely look

Zydus Cadila gets US FDA nod to market tablets for diabetic care

AHMEDABAD | MUMBAI | RAJKOT – In a press release submitted to the Indian Bourses on Tuesday, Dr Pankaj Patel led Zydus Cadila group (Cadila Healthcare Ltd.) said of having got approval from US FDA (Food & Drugs Administration) to market Sitagliptin Tablets in dosage value of 25 mg (milligram), 50 mg and 100 mg.

Sun Pharma acquires stake in Israeli Pharma Co paying US$3 million

VADODARA (BARODA) | MUMBAI | RAJKOT – In a regulatory filing submitted to the Indian Bourses on Monday, Sun Pharmaceuticals Ltd., said of having acquired 18.75% stake in Israeli Pharma company Tarsius Pharma Ltd. One of the wholly owned subsidiaries of the Company has agreed to acquire shares of Tarsius Pharma Ltd, (“Tarsius”), Israel, by

Shalby Hospitals partners INDIA BAJA NORTHERN MOTORSPORT 2018

AHMEDABAD | MUMBAI | RAJKOT – In a regulatory filing submitted to the exchanges in India on Friday, Shalby Ltd said of having successfully partenered the INDIA BAJA, a pre-qualifying motosport rally to enter DAKAR rally organized in Africa. Shalby Multi Specialty Hospitals, has became the official medical partner for the event “India Baja Northern

Zydus Cadila gets USFDA nod to market anti-viral drug

AHMEDABAD | MUMBAI | RAJKOT – Dr Pankaj Patel led Zydus Cadila Group got US FDA (Food and Drugs Administration) nod to market anti-viral drug Acyclovir Sodium Injection in composition of 500 mg and 1,000 mg, Cadila Healthcare Ltd said today, in a press release submitted to the Exchanges in India. Zydus Cadila has received

USFDA inspects JB Chem’s Panoli facilty, makes two observations

PANOLI (BHARUCH) | MUMBAI | RAJKOT – Panoli (Bharuch) unit of JB Chemicals & Pharmaceuticals Ltd has been inspected by US Food & Drugs Administration (USFDA) and the regulators have made two observations, the company said in a statement submitted to the Indian Bourses, today. The Company’s US FDA approved solid oral dosage forms formulations manufacturing